Abstract
Animal-derived drugs are currently widely-used to treat clinical lung surfactant deficiency, but synthetic surfactants have significant advantages as pharmaceutical agents. This article examines exogenous surfactants containing novel synthetic phospholipase-resistant lipids of extremely high surface activity. Mixtures of these lipid analogs with purified native surfactant apoproteins are detailed as a proof of concept for related fully-synthetic surfactants containing laboratory- produced peptides. The chemistry and biophysics of relevant lipid analogs and peptides are reviewed in the context of developing new synthetic drugs of utility for patients with surfactant deficiency or lung injury-related surfactant dysfunction.
Keywords: Synthetic lung surfactants, exogenous surfactants, phosphonolipids, lipid analogs, amphipathic peptides, surfactant peptides, acute lung injury
Mini-Reviews in Medicinal Chemistry
Title: Novel Phospholipase-Resistant Lipid/Peptide Synthetic Lung Surfactants
Volume: 7 Issue: 9
Author(s): Robert H. Notter, Adrian L. Schwan, Zhengdong Wang and Alan J. Waring
Affiliation:
Keywords: Synthetic lung surfactants, exogenous surfactants, phosphonolipids, lipid analogs, amphipathic peptides, surfactant peptides, acute lung injury
Abstract: Animal-derived drugs are currently widely-used to treat clinical lung surfactant deficiency, but synthetic surfactants have significant advantages as pharmaceutical agents. This article examines exogenous surfactants containing novel synthetic phospholipase-resistant lipids of extremely high surface activity. Mixtures of these lipid analogs with purified native surfactant apoproteins are detailed as a proof of concept for related fully-synthetic surfactants containing laboratory- produced peptides. The chemistry and biophysics of relevant lipid analogs and peptides are reviewed in the context of developing new synthetic drugs of utility for patients with surfactant deficiency or lung injury-related surfactant dysfunction.
Export Options
About this article
Cite this article as:
Notter H. Robert, Schwan L. Adrian, Wang Zhengdong and Waring J. Alan, Novel Phospholipase-Resistant Lipid/Peptide Synthetic Lung Surfactants, Mini-Reviews in Medicinal Chemistry 2007; 7 (9) . https://dx.doi.org/10.2174/138955707781662627
DOI https://dx.doi.org/10.2174/138955707781662627 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Artificial Blood: A Futuristic Dimension of Modern Day Transfusion Sciences
Cardiovascular & Hematological Agents in Medicinal Chemistry Chikungunya Infection and Immunity: An Overview
Current Immunology Reviews (Discontinued) Alcohol Abuse and HIV Infection: Role of DRD2
Current HIV Research Hypocholesterolemia
Current Vascular Pharmacology The Microbiota and Gut-Brain Axis: Contributions to the Immunopathogenesis of Schizophrenia
Current Pharmaceutical Design The Many Roles of Chemokine Receptors in Neurodegenerative Disorders: Emerging New Therapeutical Strategies
Current Medicinal Chemistry Synthetic and Natural Immunomodulators Acting as Interferon Inducers
Current Pharmaceutical Design The Role of T-Helper Cells in Atherosclerosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Immunology and Epilepsy: Clinical and Experimental Evidence
Current Immunology Reviews (Discontinued) Penetration and Effectiveness of Antiretroviral Therapy in the Central Nervous System
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Abeta DNA Vaccination for Alzheimers Disease: Focus on Disease Prevention
CNS & Neurological Disorders - Drug Targets Therapeutic Opportunities for Trophic Factors in Brain Inflammation
Current Pharmaceutical Analysis Rationale of Hyperbaric Oxygenation in Cerebral Vascular Insult
Current Vascular Pharmacology Update on ICOS: A Possible Target for Turning-Off Autoimmunity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Advances in Drug Delivery from Nose to Brain: An Overview
Current Drug Therapy Recent Achievements in Understanding Immune Recovery of Children Treated with HAART
Current Pediatric Reviews Mechanisms Governing Lentivirus Integration Site Selection
Current Gene Therapy Navigating Research Toward the Re-emerging Nipah Virus- A New Piece to the Puzzle
Current Pharmaceutical Design Intravenous Immunoglobulin Preparations and Autoimmune Disorders: Mechanisms of Action
Current Pharmaceutical Biotechnology Inhibitors of Cholinesterases in Pharmacology: the Current Trends
Mini-Reviews in Medicinal Chemistry